Epigenomics AG (EPGNF)
USD 0.79
(0.0%)
USD 0.79
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - EUR | -100.0% |
| 2022 | 61 Thousand EUR | -65.34% |
| 2021 | 176 Thousand EUR | 44.26% |
| 2020 | 122 Thousand EUR | -61.02% |
| 2019 | 313 Thousand EUR | -14.01% |
| 2018 | 364 Thousand EUR | 24.23% |
| 2017 | 293 Thousand EUR | 14.01% |
| 2016 | 257 Thousand EUR | -76.14% |
| 2015 | 1.07 Million EUR | 43.03% |
| 2014 | 753 Thousand EUR | 173.82% |
| 2013 | 275 Thousand EUR | 787.1% |
| 2012 | 31 Thousand EUR | -89.05% |
| 2011 | 283 Thousand EUR | 74.69% |
| 2010 | 162 Thousand EUR | 1.25% |
| 2009 | 160 Thousand EUR | 28.0% |
| 2008 | 125 Thousand EUR | -47.26% |
| 2007 | 237 Thousand EUR | 19.1% |
| 2006 | 199 Thousand EUR | -4.33% |
| 2005 | 208 Thousand EUR | 80.87% |
| 2004 | 115 Thousand EUR | -30.72% |
| 2003 | 166 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 209 Thousand EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | - EUR | -100.0% |
| 2023 Q4 | - EUR | 0.0% |
| 2022 Q2 | 77 Thousand EUR | -33.04% |
| 2022 Q3 | 217 Thousand EUR | 181.82% |
| 2022 Q4 | 61 Thousand EUR | -71.89% |
| 2022 FY | 61 Thousand EUR | -65.34% |
| 2022 Q1 | 115 Thousand EUR | -34.66% |
| 2021 FY | 176 Thousand EUR | 44.26% |
| 2021 Q4 | 176 Thousand EUR | -35.53% |
| 2021 Q2 | 242 Thousand EUR | -13.26% |
| 2021 Q3 | 273 Thousand EUR | 12.81% |
| 2021 Q1 | 279 Thousand EUR | 128.69% |
| 2020 Q2 | 241 Thousand EUR | -17.18% |
| 2020 Q1 | 291 Thousand EUR | -7.03% |
| 2020 Q4 | 122 Thousand EUR | -38.07% |
| 2020 FY | 122 Thousand EUR | -61.02% |
| 2020 Q3 | 197 Thousand EUR | -18.26% |
| 2019 Q3 | 302 Thousand EUR | -28.44% |
| 2019 FY | 313 Thousand EUR | -14.01% |
| 2019 Q2 | 422 Thousand EUR | -8.66% |
| 2019 Q1 | 462 Thousand EUR | 26.92% |
| 2019 Q4 | 313 Thousand EUR | 3.64% |
| 2018 FY | 364 Thousand EUR | 24.23% |
| 2018 Q4 | 364 Thousand EUR | 25.95% |
| 2018 Q2 | 358 Thousand EUR | 1.99% |
| 2018 Q1 | 351 Thousand EUR | 19.8% |
| 2018 Q3 | 289 Thousand EUR | -19.27% |
| 2017 FY | 293 Thousand EUR | 14.01% |
| 2017 Q4 | 293 Thousand EUR | 20.58% |
| 2017 Q3 | 243 Thousand EUR | -17.06% |
| 2017 Q2 | 293 Thousand EUR | -37.66% |
| 2017 Q1 | 470 Thousand EUR | 82.88% |
| 2016 Q2 | 664 Thousand EUR | -40.66% |
| 2016 Q4 | 257 Thousand EUR | -5.51% |
| 2016 FY | 257 Thousand EUR | -76.14% |
| 2016 Q1 | 1.11 Million EUR | 3.9% |
| 2016 Q3 | 272 Thousand EUR | -59.04% |
| 2015 Q1 | 1.27 Million EUR | 68.66% |
| 2015 FY | 1.07 Million EUR | 43.03% |
| 2015 Q2 | 1.46 Million EUR | 15.04% |
| 2015 Q4 | 1.07 Million EUR | -23.51% |
| 2015 Q3 | 1.4 Million EUR | -3.63% |
| 2014 Q4 | 753 Thousand EUR | -2.84% |
| 2014 Q2 | 620 Thousand EUR | 180.54% |
| 2014 FY | 753 Thousand EUR | 173.82% |
| 2014 Q1 | 221 Thousand EUR | -19.64% |
| 2014 Q3 | 775 Thousand EUR | 25.0% |
| 2013 Q3 | 250 Thousand EUR | 11.61% |
| 2013 Q4 | 275 Thousand EUR | 10.0% |
| 2013 FY | 275 Thousand EUR | 787.1% |
| 2013 Q2 | 224 Thousand EUR | 600.0% |
| 2013 Q1 | 32 Thousand EUR | 3.23% |
| 2012 Q3 | 96 Thousand EUR | -5.88% |
| 2012 FY | 31 Thousand EUR | -89.05% |
| 2012 Q4 | 31 Thousand EUR | -67.71% |
| 2012 Q2 | 102 Thousand EUR | -59.68% |
| 2012 Q1 | 253 Thousand EUR | -10.6% |
| 2011 Q1 | 105 Thousand EUR | -35.19% |
| 2011 Q2 | 128 Thousand EUR | 21.9% |
| 2011 Q3 | 362 Thousand EUR | 182.81% |
| 2011 Q4 | 283 Thousand EUR | -21.82% |
| 2011 FY | 283 Thousand EUR | 74.69% |
| 2010 Q4 | 162 Thousand EUR | 63.64% |
| 2010 FY | 162 Thousand EUR | 1.25% |
| 2010 Q1 | 54 Thousand EUR | -66.25% |
| 2010 Q2 | 81 Thousand EUR | 50.0% |
| 2010 Q3 | 99 Thousand EUR | 22.22% |
| 2009 Q4 | 160 Thousand EUR | 0.0% |
| 2009 FY | 160 Thousand EUR | 28.0% |
| 2008 FY | 125 Thousand EUR | -47.26% |
| 2007 FY | 237 Thousand EUR | 19.1% |
| 2006 FY | 199 Thousand EUR | -4.33% |
| 2005 FY | 208 Thousand EUR | 80.87% |
| 2004 FY | 115 Thousand EUR | -30.72% |
| 2003 FY | 166 Thousand EUR | 0.0% |